EDGAR Filing Documents for 0001193125-18-199545

Form 8-K - Current report:

SEC Accession No. 0001193125-18-199545

Filing Date

2018-06-21

Accepted

2018-06-21 16:32:35

Documents

Period of Report

2018-06-18

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d608225d8k.htm	8-K	28136
2	EX-10.1	d608225dex101.htm	EX-10.1	106609
3	EX-10.2	d608225dex102.htm	EX-10.2	45556
4	EX-10.3	d608225dex103.htm	EX-10.3	38463
5	EX-10.4	d608225dex104.htm	EX-10.4	44489
6	EX-10.5	d608225dex105.htm	EX-10.5	41063
	Complete submission text file	0001193125-18-199545.txt		305683

Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016

Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344

Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)